Point-of-Use Pathogen Identification Tool for Diarrhea
NCT03394040 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2020-01-06
Summary
Background:
Many people suffer from diarrhea every year. In the United States, it leads to about 130,000 hospitalizations and 3,000 deaths a year. Researchers want to test a tool that may show them what germs cause diarrhea. It is a simple paper strip test and doesn t require electric power. This may make it easier for health care workers to more quickly fight diarrheal diseases.
Objective:
To test a tool that may detect what germs cause diarrhea.
Eligibility:
People already enrolled in an active NIH protocol who have diarrhea
Design:
Participants will have 1 or 2 studies. They will give information about their symptoms, current medicines, and basic personal data. They will give a stool sample.
Part of each sample will be tested in a lab. The rest will be stored indefinitely. No personal data will be connected to the samples. The stored samples may be used in future research.
Positive test results will be reported to a participant s primary doctor
Conditions
Sponsors & Collaborators
-
National Institute of Nursing Research (NINR)
lead NIH
Principal Investigators
-
Wendy A Henderson, C.R.N.P. · National Institute of Nursing Research (NINR)
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-14
- Primary Completion
- 2019-12-23
- Completion
- 2019-12-23
Countries
- United States
Study Locations
More Related Trials
-
PTM202 and Modulation of Host Resistance to Diarrheagenic E. Coli
NCT03301103 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea
NCT00392574 ·Status: COMPLETED ·Phase: PHASE3
-
Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea
NCT01070277 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients
NCT02200328 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy of IQP-MM-101 in Reducing Symptoms of Diarrhoea
NCT01969214 ·Status: COMPLETED ·Phase: NA
-
Stool Transplant to Control Treatment-related Diarrhea
NCT04883762 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea
NCT03535272 ·Status: TERMINATED ·Phase: PHASE3
-
Probiotics for the Prevention of Antibiotics Associated Diarrhoea and Clostridium Difficile Associated Diarrhoea
NCT00973908 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
NCT00075868 ·Status: COMPLETED ·Phase: PHASE3
-
Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection
NCT03586206 ·Status: UNKNOWN
-
A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)
NCT05153499 ·Status: TERMINATED ·Phase: PHASE3
-
OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)
NCT00097422 ·Status: COMPLETED ·Phase: PHASE2
-
Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea
NCT00098384 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Vancomycin for Preventing Clostridium Difficile Recurrence
NCT03200093 ·Status: TERMINATED ·Phase: PHASE4
-
Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease
NCT00384527 ·Status: TERMINATED ·Phase: PHASE3
-
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea
NCT00034294 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea
NCT02801656 ·Status: WITHDRAWN ·Phase: PHASE3
-
Fecal Calprotectin: Cheap Marker for Diagnosing Acute Infectious Diarrhea
NCT00429325 ·Status: COMPLETED
-
CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Diarrhoea in Adults
NCT06839599 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents
NCT00366236 ·Status: COMPLETED ·Phase: PHASE3
-
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
NCT07250724 ·Status: RECRUITING
-
Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study
NCT01040325 ·Status: COMPLETED ·Phase: PHASE2
-
Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile
NCT05389904 ·Status: RECRUITING ·Phase: NA
-
Freeze-dried, Capsulized FMT for RCDI
NCT02399618 ·Status: UNKNOWN ·Phase: PHASE1